T-cell immunotherapiesCRCMSS colorectal cancer
…crosatellite stable (MSS) colorectal cancer (CRC) to respond to T-cell immunotherapies can be contributed by innate immune dysregulation in the tumor …
1articles mentioning treatments
1treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: T-cell immunotherapies ×
T-cell immunotherapies
This treatment is selected. Its supporting articles are shown below.